Aaron Kesselheim (2009 Awardee) co-authored "New FDA Breakthrough-Drug Category — Implications for Patients" published in the New England Journal of Medicine (2014; 370:1252-1258).
News Source:
Date:
Thursday, March 27, 2014
Investigator:
Aaron Kesselheim (2009 Awardee) co-authored "New FDA Breakthrough-Drug Category — Implications for Patients" published in the New England Journal of Medicine (2014; 370:1252-1258).